A China cosmetic supplier may send a factory registration reference, ingredient list, label artwork, product specification, manufacturing record, supplier declaration, screenshot, or email when a buyer asks for FDA MoCRA-related information. These materials can help a buyer trace what the supplier says about a product and site. They do not, by themselves, show FDA approval, confirm a current facility registration or product listing, identify the responsible person, establish safety substantiation, or authorize product release.
China supplier cosmetic facility registration evidence is buyer-side evidence that links a buyer product/SKU/version, product and label identity, supplier legal entity/site, stated manufacturing or processing role, supplier-provided facility identity, source record/date, responsible-person/label relationship, supplied facility-registration or product-listing reference, supplied ingredient/label association, shipment association, and buyer owner. It does not establish that a facility requires registration, that a product requires listing, that any submission is complete, current, or accepted, that a supplier is the responsible person, that a product is FDA-approved, that a formula or label is compliant, that safety substantiation is adequate, or that a product may be marketed or released.
The goal is a traceable record, not a regulatory conclusion. Questions about product scope, facility registration, product listing, responsible-person role, label and ingredient review, safety substantiation, FDA submissions, product disposition, and release remain with the buyer’s qualified responsible functions.
Keep supplier records separate from FDA approval and submission actions
FDA says manufacturers and processors must register cosmetic facilities and renew the registration every two years. It also says that a responsible person must list each marketed cosmetic product with FDA, including product ingredients, and provide annual updates.1 These duties concern defined roles and products. A China supplier’s file may contain useful facts about a facility or product, but it does not show that a required action has been completed or accepted.
FDA defines a responsible person as the manufacturer, packer, or distributor whose name appears on the product label in the stated statutory context.2 The supplier who makes a product in China may provide manufacturing information, but the buyer evidence file should not assume the supplier is the responsible person merely because it manufactured the product or supplied a formula.
FDA also gives a direct boundary: cosmetic product facility registration and product listing are neither a cosmetic approval program nor a promotional tool, and FDA does not issue certificates for those registrations or listings.1 A sourcing record should preserve a supplier statement as a statement. It should not convert the statement, number, screenshot, or document title into an FDA approval claim.
Set the evidence boundary before requesting cosmetic documents
A supplier file can identify a product, factory, ingredient declaration, label draft, facility reference, or listing reference. It can make a qualified review easier. It cannot establish FDA approval, registration/listing status, label compliance, safety substantiation, or shipment-release status.
| Buyer review subject | A supplier record can identify | A supplier record cannot establish |
|---|---|---|
| Buyer product/version | Buyer-stated commercial scope | Cosmetic-versus-drug classification |
| Supplier legal entity/site | Stated source of information | Required registration outcome |
| Manufacturing/processing role | Supplier-stated activity | Responsible-person determination |
| Facility reference | Supplier-provided facility detail | Current, complete, or accepted registration |
| Product-listing reference | Supplier-provided product detail | Current, complete, or accepted listing |
| Ingredient/label record | Supplier-provided source information | Ingredient or label compliance |
| Safety record | Supplier-provided test or source file | Adequate safety substantiation |
| Shipment association | Stated product/transaction link | Marketing or release approval |
Use factual wording. “Supplier supplied facility reference FR-22 for buyer SKU C-06” is a record entry. “SKU C-06 is FDA approved and registered” is not a conclusion that the supplier file can establish.
Define product, site, label, and source scope
Start with the buyer product or SKU, current version, product description, and label identity. Identify the supplier legal entity and site that supplied the information. Then capture the supplier’s stated manufacturing or processing role, facility identity, facility-registration or product-listing reference it provides, ingredient and label association, source record/date, shipment association, and buyer owner.
Product identity should be exact. A supplier may use a factory formula code, while a buyer uses a brand name, retail SKU, or label revision. An ingredient document may describe a base formula, while the final buyer product has a different color, fragrance, or package size. Do not assume the records describe the same finished product. Preserve the relationship stated by the supplier and make an unclear version or label link visible.
| Scope field | Buyer record purpose |
|---|---|
| Buyer product/SKU and version | Identifies buyer-stated product scope |
| Buyer label/brand reference | Identifies buyer-stated commercial identity |
| Supplier legal entity/site | Identifies information source |
| Manufacturing/processing role | Identifies supplier-stated activity |
| Facility identity/reference | Identifies supplied facility information |
| Product-listing reference | Identifies supplied product information |
| Ingredient/label record | Identifies supplier-provided association |
| Source file/date | Identifies traceable evidence object |
| Shipment association | Identifies stated transaction link |
| Buyer owner | Identifies responsible follow-up route |
Ask for facts, not an FDA outcome
A buyer can ask a China supplier to identify the product/version, legal entity/site, manufacturing role, product and label reference, available facility and product records, source file/date, ingredient and label information it can provide, change information, shipment association, and a contact for clarification. The supplier can identify records it does not maintain or cannot share.
The request should not tell the supplier to decide whether a product is a cosmetic or drug, determine whether a facility must register, make an FDA facility registration or product listing, decide who is the responsible person, assess safety substantiation, approve a label, or clear a shipment. FDA’s materials identify separate facility and responsible-person roles, and separate registration/listing processes.1
| Supplier-stated evidence | Buyer question | Review limit |
|---|---|---|
| Product/version identity | Which product/version does the supplier identify? | It does not decide product scope |
| Supplier/site identity | Which entity and site supplied the record? | It does not establish registration status |
| Manufacturing role | What activity does the supplier state it performs? | It does not identify responsible person |
| Facility reference | What facility information is supplied? | It does not verify current registration |
| Listing reference | What product information is supplied? | It does not verify current listing |
| Ingredient/label record | Which formula and label relation is stated? | It does not establish compliance |
| Change/shipment association | Which change or shipment is stated? | It does not authorize marketing or release |
Keep related records separate
Supplier evidence, facility-registration action, product-listing action, responsible-person determination, label or ingredient review, safety-substantiation record, FDA submission status, supplier status, product disposition, and shipment release are separate records. They may concern the same product, but their owners and meanings differ.
FDA’s guidance explains that a facility registration includes facility identity and address details, foreign-facility U.S.-agent information, brand names, product categories, and responsible-person information under the stated requirements.3 Product listings have their own information requirements, including facility information, responsible-person and product-label information, category, and ingredient information.3 A buyer evidence map can organize what a supplier provides on these subjects. It should not decide that a registration or listing is required, complete, current, or accurate.
| Evidence object | Factual relationship to capture |
|---|---|
| Supplier product record | Supplier-stated product/version and source file |
| Supplier site record | Supplier-stated legal entity/site and activity |
| Facility reference | Supplier-provided facility information |
| Product-listing reference | Supplier-provided product information |
| Ingredient/label record | Supplier-provided formula/label relationship |
| Responsible-person record | Separate qualified role determination |
| Registration/listing action | Separate controlled FDA submission process |
| Safety/release record | Separate qualified assessment and decision |
Map evidence to the exact buyer product and label version
Place the buyer product, version, and label reference at the center of the evidence map. Link supplier legal entity/site, manufacturing role, facility reference, product-listing reference, ingredient/label record, source file/date, shipment association, and buyer owner. This gives a reviewer a factual trail without calling any source a confirmation of registration, listing, or approval.
China supplier cosmetic facility registration evidence is most useful when it shows the relationship between a source record and a current product or site. A factory identifier can be a useful reference. A qualified function still needs to determine what it means for a particular product, label, responsible person, or submission process.
FDA’s guidance says that a product listing contains a facility registration number for each facility where a product is manufactured or processed, subject to the stated treatment of facilities exempt from registration.3 A buyer record can preserve a supplier-provided site or reference. It should not infer that a product listing exists or that the supplied relationship is complete.
Preserve gaps without making regulatory conclusions
An unclear product/version, supplier/site mismatch, missing source record, unclear facility or listing reference, absent label association, unclear ingredient relationship, unknown status, or unassigned owner should receive a neutral record entry. That entry records the evidence condition without deciding the status of the product or facility.
| Record condition | Neutral buyer statement | It does not mean |
|---|---|---|
| Product/version is unclear | Supplier file does not identify a clear buyer version | Product is noncompliant |
| Site/entity differs | Supplier records need source identity clarification | Facility is unregistered |
| Source record is missing | Supplier did not provide the requested file | No submission exists |
| Facility reference is unclear | Supplier record needs reference clarification | Registration is invalid |
| Listing reference is unclear | Supplier file lacks a clear product connection | Product is unlisted |
| Label association is absent | Record does not identify a buyer label version | Label is noncompliant |
| Ingredient relation is unclear | Formula source is not tied to buyer version | Ingredients are unacceptable |
| Owner is unassigned | Follow-up route is not recorded | Marketing or release is authorized |
| ## Use a restrained buyer review sequence |
Start with the buyer’s current product baseline. Record the buyer SKU, product version, label revision, brand identity, and controlled product reference. Identify the supplier legal entity and site that supplied each file. This avoids treating a document from an old formula, another factory, or a prior label as evidence for the current buyer product.
Capture the supplier’s facts as supplied. Record its product description, site and activity, facility or listing reference, ingredient or label record, source file/date, and stated shipment association. Preserve the original source file when the information is in Chinese. A working translation can help a buyer route an issue, but it does not turn a supplier statement into FDA approval, a registration confirmation, a listing confirmation, or a release decision.
Then name the owner of the next question. The owner may need to reconcile a factory formula with a buyer label, review a responsible-person relationship, determine whether a registration or listing process applies, assess label or ingredient records, or resolve a supplier/site mismatch. The evidence log should state that route rather than use a broad status such as “FDA registered.”
| Review step | Buyer action | Boundary kept intact |
|---|---|---|
| Establish baseline | Identify product, version, label, and buyer reference | Does not decide product scope |
| Identify source | Record supplier entity, site, file, and date | Does not establish registration status |
| Capture statement | Preserve supplied facility/product/label information | Does not make an FDA submission |
| Map association | Link file to buyer product, version, or shipment | Does not identify responsible person |
| Surface gap | Log unclear or absent relationship | Does not decide compliance |
| Assign route | Name responsible owner and question | Does not authorize marketing or release |
This sequence prevents a familiar sourcing shortcut: treating a number, screenshot, or document called a “registration certificate” as proof of FDA approval or a current status. FDA itself says registration and listing are not an approval program and that it does not issue certificates for those actions.1
Build a compact China supplier cosmetic facility registration evidence record sheet
A compact record sheet should make supplier information easy to recover without becoming an approval form. It should identify the buyer product, source record, stated association, open condition, and owner. Do not use it to label an item FDA approved, facility registered, product listed, label approved, sale approved, or released unless a separate controlled process has made the relevant determination or action.
| Field | Example factual entry |
|---|---|
| Buyer product/version/brand | Buyer SKU, revision, and brand reference |
| Buyer label reference | Current label/artwork revision |
| Supplier source | Supplier-stated legal entity and site |
| Manufacturing role | Supplier-stated activity |
| Facility reference | Supplier-provided facility identity/detail |
| Product-listing reference | Supplier-provided product identity/detail |
| Ingredient/label record | Supplier-provided source association |
| Source record | File name, date, and supplier contact |
| Shipment association | Supplier-stated product/shipment link |
| Open condition | Missing detail, mismatch, or unclear relationship |
| Buyer owner | Function responsible for follow-up |
FDA’s product-listing guidance describes product information, facility information, responsible-person details, label name, product category, and ingredient information in the stated submission context.3 A buyer sheet can store supplier-provided source material that relates to those subjects. It does not verify that the information is correct, current, complete, or submitted to FDA.
Keep supplier records and FDA actions distinct
FDA says that a responsible person must list each marketed cosmetic product and include product ingredients, with annual updates.1 A supplier ingredient list or label draft may be useful input to a qualified buyer process. It is not the responsible person’s product-listing action or confirmation that an FDA listing exists.
FDA’s MoCRA page also says that responsible persons must ensure and maintain records supporting adequate safety substantiation for cosmetic products.2 A supplier test report, formulation detail, or product statement can be a source record. The buyer evidence map should not call it adequate safety substantiation or decide a safety conclusion.
China supplier cosmetic facility registration evidence should identify the exact product/version, supplier site, and source-file relationship. A file with a similar product name, a facility reference with no site connection, or an ingredient list without a link to the buyer label remains a source record. Preserve it and route the missing relationship instead of treating it as a current regulatory result.
Make handoffs readable for qualified owners
A useful handoff identifies the buyer product, source record, and actual question. Regulatory or legal functions may need the supplier files and a precise description of gaps. A responsible-person function may need a current label and product identity. Quality and supplier-management functions may need to reconcile a site or source-document mismatch. A technical or safety function may need to evaluate product/ingredient information under its own controlled process.
| Owner route | Question a buyer record can present |
|---|---|
| Product-scope function | What product classification question remains for this item? |
| Facility-registration function | What site/source facts are available for the relevant process? |
| Product-listing function | What product/label/ingredient records are available? |
| Responsible-person function | What label and role information is supplied? |
| Label/ingredient review | What source product information needs qualified review? |
| Safety function | What supplier records are available for its controlled assessment? |
| Legal/regulatory function | What factual records and open questions need review? |
| Quality/supplier management | Which supplier entity/site and file apply to the item? |
| Disposition/release authority | Is a separate controlled decision recorded for product state? |
A complete China supplier cosmetic facility registration evidence record gives the buyer a factual basis to request clarification of manufacturing, facility, formula, and label records without asking the supplier to decide an FDA obligation or product outcome outside its role.
Avoid predictable record-control failures
Do not rely on a document title. A China supplier file named “FDA registration” may be a commercial declaration, a site identifier, an application record, a screenshot, or another source file. Record the issuer, source date, legal entity/site, product relationship, and stated purpose. If the relationship is unclear, preserve the gap.
Do not assume a facility reference applies to every buyer product. The FDA guidance describes a facility-registration and product-listing information relationship that depends on the relevant facility and product context.3 Keep product, site, label, and supplier-source associations visible rather than applying one supplier document to all factory products.
Do not use supplier identity as proof of the responsible-person role. FDA defines the responsible person in relation to the name appearing on a product label.1 A China supplier can make or process the product and still not be the person whose name appears on the buyer label. Preserve the label and supplier facts, then route the role question.
Do not merge facility evidence with product disposition. A buyer can have a supplier file about a facility while still needing separate work on product scope, label/ingredient review, safety records, registration/listing actions, supplier status, and release. Treat each as its own record and owner route.
Frequently asked questions
Does a China supplier facility reference prove FDA approval?
No. FDA says cosmetic facility registration and product listing are neither a cosmetic approval program nor a promotional tool, and FDA does not issue certificates for these actions.1 A supplier reference can be a source record; it does not prove approval.
Who is the responsible person for a cosmetic product?
FDA defines a responsible person as the manufacturer, packer, or distributor whose name appears on the product label in the stated legal context.2 A buyer record can preserve the supplier identity and current label. The responsible-person determination should stay with the qualified responsible function.
What can a buyer request from a China cosmetic supplier?
Request product/version and label identity, supplier legal entity/site, stated manufacturing role, supplier-provided facility and product references, ingredient/label source records, source document/date, stated change information, shipment association, and a contact. Do not ask the supplier to decide FDA approval, required registration/listing, responsible-person status, or release outside its role.
Does a supplier ingredient list prove that a product listing is complete or current?
No. A supplier ingredient list may be a useful source record. FDA says a responsible person must list each marketed cosmetic product, including ingredients, and provide annual updates.1 The supplier list does not establish the completion, currency, or acceptance of a listing.
Does supplier evidence authorize shipment release or sale?
No. Supplier records can support a qualified review. They do not establish FDA approval, facility registration, product listing, label compliance, safety substantiation, product disposition, marketing permission, or shipment release. Keep those as separate controlled actions and decisions.
Keep supplier facts and FDA actions distinct
A useful China supplier cosmetic facility registration evidence record identifies the buyer product/version and label, supplier/site, manufacturing role, supplied facility and listing references, ingredient/label associations, source file/date, shipment association, open conditions, and owner. It makes supplier records traceable without calling them FDA approval, registration confirmation, listing confirmation, or release approval.
That boundary makes later review clearer. Qualified functions can see exactly what the supplier provided, which buyer product and site it concerns, and what remains unresolved. The roles responsible for FDA, product, label, safety, and release processes retain control of their own actions.
Supplier Ally can help buyers organize supplier communications, product specifications, facility/site records, formula and label source files, change notices, shipment references, and evidence requests across China sourcing projects. Decisions about product scope, FDA registration or listing actions, responsible-person status, label or ingredient review, safety substantiation, legal interpretation, product disposition, and release should remain with the buyer’s qualified responsible functions.
ES 
EN 